A systematic UHPLC-Q-TOF-MS/MS-based strategy for analysis of chemical constituents and related in vivo metabolites of Buyang Huanwu decoction
Qingping Xiong,Heng Li,Yajuan Yan,Zhimin Yan,Yingying Shi,Rong Wang,Siting Cheng,Zhipeng Deng,Guangzhen Zheng,Mingtao Tao,Xiangyang Cao,Yadong Yu,Dongbing He,Daiyin Peng
DOI: https://doi.org/10.1016/j.jep.2024.118987
IF: 5.195
2024-10-29
Journal of Ethnopharmacology
Abstract:Ethnopharmacological relevance Buyang Huanwu Decoction (BYHWD), a traditional Chinese medicine, is one of the classic prescriptions for the treatment of ischemic stroke in clinical practice. It has the effects of tonifying qi, activating blood circulation, and promoting meridian circulation. However, its chemical analysis has not been clarified, which greatly hinders its further clinical application. Therefore, it is necessary to clarify the chemical constituents and metabolites profile of BYHWD in vivo . Aim of the study Characterizing the chemical basis of BYHWD in vitro , and combing studies of related metabolism in vivo to screen out the potential active components of BYHWD with pharmacological effects in vivo . Materials and methods Twelve male rats weighed 200 ± 20 each were selected for the experiments. According to the fragmentation of different structural types of components and diagnostic ions, UHPLC-Q-TOF-MS/MS was used to classify and clarify the unknown components of BYHWD and identify the material basis of BYHWD in vitro . Then, rat plasma, tissues, feces, and urine were collected for analysis. Based on the similarity of MS responses (accurate molecular weight and secondary fragmentation) and chromatographic behavior (retention time), the in vivo prototype and metabolites were analyzed. Through the phase I and phase II metabolism law, a metabolite library was established to analyze the prototype-matched metabolites. Results A total of 121 in vitro compounds and 55 in vivo prototypes of BYHWD were identified, corresponding to 123 matched prototypes. It was mainly composed of flavonoids, triterpene saponins, nucleosides and lactones both in vitro and in vivo . Quercetin, ligustilide, astragaloside IV, calycosin, paeoniflorin and ferulic acid were the main prototypes and metabolites in plasma and urine. Conclusion Quercetin, ligustilide, astragaloside IV, calycosin, paeoniflorin and ferulic acid were the main active ingredients of BYHWD.
pharmacology & pharmacy,chemistry, medicinal,integrative & complementary medicine,plant sciences